Number of the records: 1
apolipoproteín A-I
SYS d016632 LBL 00000cz--a2200000n--4500 005 20250606214032.7 008 920124|||anznnbabn-----------|-a|a------ 040 $b slo $a DNLM $d BA006 $d BA006 065 $a D10.532.091.200.100 065 $a D12.776.070.400.200.100 065 $a D12.776.521.120.200.100 066 $a 01 $c 03 150 $a apolipoproteín A-I $x AD $x AE $x AG $x AI $x AN $x BI $x BL $x CF $x CH $x CL $x CS $x DE $x DF $x EC $x GE $x HI $x IM $x IP $x ME $x PD $x PH $x PK $x PO $x RE $x SD $x ST $x TO $x TU $x UL $x UR $2 slo 450 $w v $a Apo A-I $2 eng 450 $w v $a apo A-I $2 slo 450 $w v $a ApoAI $2 slo 665 $a 1992 (1974); for PRO-APOLIPOPROTEIN A-I (NM) use APOLIPOPROTEINS A & PROTEIN PRECURSORS 1983-2006; for APOLIPOPROTEIN A-I ISOPROTEINS (NM) use APOLIPOPROTEINS A 1980-2006 $2 eng 665 $a Apolipoproteins (1977-1984) $2 eng 665 $a Apolipoproteins A (1985-1991) $2 eng 680 9-
$i The most abundant protein component of HIGH DENSITY LIPOPROTEINS or HDL. This protein serves as an acceptor for CHOLESTEROL released from cells thus promoting efflux of cholesterol to HDL then to the LIVER for excretion from the body (reverse cholesterol transport). It also acts as a cofactor for LECITHIN CHOLESTEROL ACYLTRANSFERASE that forms CHOLESTEROL ESTERS on the HDL particles. Mutations of this gene APOA1 cause HDL deficiency, such as in FAMILIAL ALPHA LIPOPROTEIN DEFICIENCY DISEASE and in some patients with TANGIER DISEASE. $2 eng 750 -2
$a Apolipoprotein A-I $2 eng 980 $x M
Number of the records: 1